Welcome to our dedicated page for Trinseo PLC news (Ticker: $TSE), a resource for investors and traders seeking the latest updates and insights on Trinseo PLC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Trinseo PLC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Trinseo PLC's position in the market.
Trinseo reported a net loss of $76 million and EPS of negative $2.14 in the first quarter of 2024. Adjusted EBITDA was $45 million, with a $13 million favorable impact from net timing. Cash used in operations was $66 million, resulting in Free Cash Flow of negative $82 million. The company extended the maturity date of its Accounts Receivable Securitization Facility and announced the potential closure of a production site in Stade, Germany. Net sales decreased by 9% compared to the prior year, driven by lower prices and sales volumes. Trinseo is optimistic about margin expansion in the second quarter, despite higher working capital costs in Q1.